When the World Health Organisation (WHO) became pro CBD
CBD can be described as a component of more than 100 different types of cannabinoids found in Cannabis plants. The scientific community believes that CBD gives the plant a strong therapeutic profile.
CBD products pose legal issues because they are closely related to Tetrahydrocannabinol, the active ingredient in cannabis. This compound is responsible for the psychoactivity of cannabis. Both components can be found in cannabis plants, so CBD products will always contain traces of THC. This will vary depending on the variety or strain of the plant.
The World Health Organization (WHO), in a CBD Review Report 2017, determined that CBD does not cause addiction and produce harmful effects on the health. It also certifies that CBD offers a wide range of medicinal benefits such as the relief of pain, anxiety, improvement of neurodegenerative conditions such as Alzheimer’s, Parkinson’s, Multiple Sclerosis, and helps to prevent skin and/or condition disorders.
The WHO also proposed to the United Nations Organization to lower the international control over cannabis and remove it (List IV of 1961 Single Convention on Narcotic Drugs), to make it to List I, substances to which therapeutic qualities and less control are recognized.